Morphologic evaluation of the antitumor activity of photodynamic therapy (PDT) using mono-L-aspartyl chlorin e6 (NPe6) against uterine cervical carcinoma cell lines

International Journal of Gynecological Cancer

Volumn 12, Issue 2, 2002, Pages 177-186

  Nakamura, H ^a   Suzuki, Y ^a   Takeichi, M ^a   Saito, T ^a   Takayama, M ^a   Aizawa, K ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Mono L aspartyl chlorin e6 (NPe6); Photodynamic therapy (PDT); Uterine cervical carcinoma

Indexed keywords

LEVO ASPARTYLCHLORIN E6; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD VESSEL OCCLUSION; CANCER INHIBITION; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TUMOR CELL LINE; TUMOR NECROSIS; UMBILICAL CORD; UTERINE CERVIX CARCINOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA; CELL LINE; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; LASERS; MALE; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0036249829     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2002.01087.x     Document Type: Article

References (22)

1. Photoradiation in the treatment of recurrent breast carcinoma
2. Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer
3. Fluorescence fiberoptic bronchoscopy in the diagnosis of early stage lung cancer
4. Photosensitizing efficiencies, tumor and cellular uptake of different photosensitizing drugs relevant for photodynamic therapy of cancer
5. Localization of mono-L-aspartyl chlorin e6 (NPe6) in mouse tissues
6. In vivo studies on the utilization of mono-L-aspartyl chlorin (NPe6) for photodynamic therapy
7. In vitro characterization of monoaspartyl chlorin e6 and diaspartyl chlorin e6 for photodynamic therapy
8. In vitro photosensitization I. Cellular uptake and subcellular localization of mono-L-aspartyl chlorin e6, chloro-aluminum sulfonated phthalocyanine, and photofrin II
9. In vitro photosensitization II. An electron microscopy study of cellular destruction with mono-L-aspartyl chlorin e6 and photofrin II
10. Determinants of photosensitization by mono-L-aspartyl chlorin e6
11. Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model
12. Lipoprotein-mediated distribution of N-aspartyl chlorin-E6 in the mouse
13. Photosensitizing properties of mono-L-aspartyl chlorin e6 (NPe6): A candidate sensitizer for the photodynamic therapy of tumors
14. Transadventitial localisation of atheromatous plaques by fluorescence emission spectrum analysis of mono-L-aspartyl chlorin e6
15. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor
16. Five-year disease-free survival of a lung cancer patient treated only by photodynamic therapy
17. Photodynamic therapy - New approaches
18. Tumor destruction in photodynamic therapy
19. A new diagnostic system for malignant tumors using hematoporphyrin derivative, laser photoradiation and a spectroscope
20. The tumourlocalizing properties of porphyrin derivatives
21. Interaction of bovine serum albumin with mono-L-aspartyl chlorine e6 by spectrophotometry
22. Dynamics of photosensitizer in the cell